cccDNA
微小染色体
乙型肝炎病毒
环状DNA
表观遗传学
病毒学
可药性
生物
乙型肝炎
病毒
基因沉默
免疫学
DNA
遗传学
染色质
乙型肝炎表面抗原
基因
基因组
作者
Zhaoning Wang,Weiwei Wang,Lanfeng Wang
出处
期刊:Biophysics reports
[Chinese Academy of Sciences]
日期:2020-07-25
卷期号:6 (4): 115-126
被引量:5
标识
DOI:10.1007/s41048-020-00112-z
摘要
Hepatitis B is caused by hepatitis B virus (HBV), and persistent HBV infection is a global public health problem, with 257 million people as HBV chronic carriers. Viral covalently closed circular DNA (cccDNA) is a key factor to establish persistent infection in infected hepatocytes. Current antiviral therapies have no direct impact on pre-existing cccDNA reservoir, which can be assembled into minichromosome by hijacking host factors. Understanding the mechanisms of epigenetic regulation in cccDNA minichromosome is crucial to develop new therapy on cccDNA, an attractive target for HBV cure. This review summarizes the current advances in epigenetic regulation of cccDNA minichromosome, which might provide clues to novel druggable targets to cure hepatitis B by either silencing or eliminating cccDNA reservoir.
科研通智能强力驱动
Strongly Powered by AbleSci AI